| LDR | | 00000nmm u2200205 4500 |
| 001 | | 000000333730 |
| 005 | | 20250120144519 |
| 008 | | 181129s2018 ||| | | | eng d |
| 020 | |
▼a 9780438290600 |
| 035 | |
▼a (MiAaPQ)AAI10824591 |
| 035 | |
▼a (MiAaPQ)ucdavis:17897 |
| 040 | |
▼a MiAaPQ
▼c MiAaPQ
▼d 248032 |
| 049 | 1 |
▼f DP |
| 082 | 0 |
▼a 615 |
| 100 | 1 |
▼a Ellinwood, Nicholas. |
| 245 | 10 |
▼a Computational Approaches to Atrial Fibrillation-selective Antiarrhythmic Therapy. |
| 260 | |
▼a [S.l.] :
▼b University of California, Davis.,
▼c 2018 |
| 260 | 1 |
▼a Ann Arbor :
▼b ProQuest Dissertations & Theses,
▼c 2018 |
| 300 | |
▼a 176 p. |
| 500 | |
▼a Source: Dissertation Abstracts International, Volume: 80-01(E), Section: B. |
| 500 | |
▼a Adviser: Eleonora Grandi. |
| 502 | 1 |
▼a Thesis (Ph.D.)--University of California, Davis, 2018. |
| 520 | |
▼a Atrial fibrillation (AF) is the most common cardiac arrhythmia (affecting &sim |
| 520 | |
▼a To maximize efficacy and minimize proarrhythmic risk, an AF-selective drug should exert potent effects on fibrillating atria without significantly impacting ventricular tissue function during normal sinus rhythm (nSR). A potential strategy to ac |
| 590 | |
▼a School code: 0029. |
| 650 | 4 |
▼a Pharmacology. |
| 690 | |
▼a 0419 |
| 710 | 20 |
▼a University of California, Davis.
▼b Pharmacology and Toxicology. |
| 773 | 0 |
▼t Dissertation Abstracts International
▼g 80-01B(E). |
| 773 | |
▼t Dissertation Abstract International |
| 790 | |
▼a 0029 |
| 791 | |
▼a Ph.D. |
| 792 | |
▼a 2018 |
| 793 | |
▼a English |
| 856 | 40 |
▼u http://www.riss.kr/pdu/ddodLink.do?id=T14998679
▼n KERIS |
| 980 | |
▼a 201812
▼f 2019 |
| 990 | |
▼a 관리자
▼b 관리자 |